honokiol has been researched along with Cardiotoxicity in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Cheng, P; Cheng, TT; Huang, AL; Ji, XL; Liao, DY; Ma, L; Peng, DD; Xia, XG; Yang, F; Zhang, L; Zhou, L | 1 |
Li, Y; Liu, R; Sun, N; Xiong, F | 1 |
Chen, L; Guo, Y; Huang, F; Huang, K; Huang, L; Long, Q; Yang, K; Yang, Q; Zhang, F; Zhang, K | 1 |
3 other study(ies) available for honokiol and Cardiotoxicity
Article | Year |
---|---|
Honokiol attenuate the arsenic trioxide-induced cardiotoxicity by reducing the myocardial apoptosis.
Topics: Animals; Apoptosis; Arsenic Trioxide; Biphenyl Compounds; Cardiotoxicity; Lignans; Magnolia; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mitochondria; Myocytes, Cardiac; Oxidative Stress; Reactive Oxygen Species | 2022 |
[Honokiol reduces doxorubicin-induced cardiotoxicity
Topics: Allyl Compounds; AMP-Activated Protein Kinases; Biphenyl Compounds; Cardiotoxicity; Caspase 3; Cytochromes c; Doxorubicin; Humans; Interleukin-6; Myocytes, Cardiac; NF-E2-Related Factor 2; NLR Family, Pyrin Domain-Containing 3 Protein; Phenols; Pyroptosis; RNA, Messenger; Tumor Necrosis Factor-alpha | 2022 |
Honokiol protects against doxorubicin cardiotoxicity via improving mitochondrial function in mouse hearts.
Topics: Animals; Anti-Arrhythmia Agents; Antibiotics, Antineoplastic; Biphenyl Compounds; Cardiotoxicity; Cell Respiration; Doxorubicin; Heart; Lignans; Mice, Inbred C57BL; Mitochondria; Oxygen | 2017 |